Friday, April 24, 2015 5:38:22 PM
Actually we are probably at historic lows on short interest when taking into account outstanding shares that have increased
Will be nice once stock options are granted in another week or so
4/15/2015 10,395,362
3/31/2015 11,061,472 1,335,346 8.283600
03/13/2015 11,046,367 (1.67) 2,022,155 5.46
02/27/2015 11,234,083 (1.43) 1,323,892 8.49
02/13/2015 11,397,270 7.78 1,006,628 11.32
01/30/2015 10,574,415 (0.68) 849,744 12.44
01/15/2015 10,646,463 (5.17) 1,462,226 7.28
12/31/2014 11,226,599 (6.39) 842,439 13.33
12/15/2014 11,992,739 (4.66) 827,822 14.49
11/28/2014 12,579,396 (4.33) 568,737 22.12
11/14/2014 13,149,070 3.40 670,652 19.61
10/31/2014 12,716,882 (7.17) 1,239,134 10.26
10/15/2014 13,698,502 (2.97) 1,687,335 8.1
9/30/2014 14,117,151 945,827 14.925722
9/15/2014 14,600,682 1,010,060 14.455262
9/15/2014 14,600,682 1,010,060 14.455262
8/29/2014 15,736,182 503,499 31.253651
8/15/2014 15,793,549 924,495 17.083434
7/31/2014 16,146,644 1,218,060 13.256033
7/15/2014 16,418,715 1,447,658 11.341570
06/30/2014 15,263,090 (1.35) 1,208,520 12.63
06/13/2014 15,472,305 0.16 979,604 15.79
05/30/2014 15,447,284 (4.20) 1,259,592 12.26
4/15/2014 15,358,319 3,069,961 5.002773
3/31/2014 15,082,020 3,252,210 4.637468
3/14/2014 15,610,186 11,996,271 1.301253
2/28/2014 10,280,960 1,869,901 5.498131
02/14/2014 10,244,573 1.67 2,269,345 4.51
01/31/2014 10,075,940 13.81 4,793,912 2.10
01/15/2014 8,852,918 4.42 6,454,605 1.37
12/31/2013 8,478,508 (2.11) 1,385,265 6.12
12/13/2013 8,661,584 (7.98) 1,134,876 7.63
11/29/2013 9,413,042 (4.48) 1,016,454 9.26
11/15/2013 9,854,527 1.06 1,190,725 8.28
10/31/2013 9,751,269 (3.76) 1,337,858 7.29
10/15/2013 10,132,721 (34.83) 1,396,924 7.25
09/30/2013 15,547,091 (0.86) 746,493 20.83
09/13/2013 15,681,288 (2.65) 1,288,033 12.17
08/30/2013 16,107,814 (1.53) 717,696 22.44
08/15/2013 16,357,614 (2.54) 1,086,600 15.05
07/31/2013 16,783,378 (5.87) 1,359,808 12.34
06/14/2013 11,848,918 8.35 2,751,147 4.31
05/31/2013 10,936,051 (1.19) 4,552,703 2.40
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
Recent CDMO News
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/19/2023 09:05:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:34:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:33:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:32:11 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM